S25-550 Antibody-Targeted Molecular Glue Degraders for Selective Cancer Therapy Stanford researchers have developed degrader-antibody conjugates that deliver hyper-potent molecular glue degraders directly to tumor cells. Steven Corsello Nathanael Gray Md Abdullah Al Noman Tinghu Zhang